ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

POLB Poolbeg Pharma Plc

7.65
0.05 (0.66%)
Last Updated: 08:19:14
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Poolbeg Pharma Plc LSE:POLB London Ordinary Share GB00BKPG7Z60 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.66% 7.65 7.60 7.70 7.70 7.65 7.70 64,978 08:19:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -3.93M -0.0079 -9.68 38M
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 7.60p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 7.15p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £38 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -9.68.

Poolbeg Pharma Share Discussion Threads

Showing 3451 to 3475 of 3750 messages
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
23/7/2024
17:19
I wonder after today's news will Poolbeg be looking for new premises.
Friel cannot remain Chairman of Hvivo and he's the only tie between the 2 entities after the spinout

chica1
22/7/2024
07:33
Should come down cheesy this week;))
baldrick1
16/7/2024
15:11
Like a Mcdonald whopper??? ;))
baldrick1
15/7/2024
14:13
That was a whopper of a trade.
chica1
15/7/2024
07:41
12.50p-13p a very interesting target.
baldrick1
10/7/2024
10:03
peterrr3
they have found interesting targets with the AI tool and are looking into them, all part of the pipeline. I personally would be very surprised if they didnt considering the quality of the database they are mining.

pogue
10/7/2024
09:16
The patent office reckon they have nothing unique with their AI prediction algorithm, but let's hope that doesn't stop them finding something useful with it, just means they don't have anything to license off the AI tools.
peterrr3
10/7/2024
09:15
Did he pay 11p, same as the chairman??
baldrick1
10/7/2024
08:00
Looks like Michael Kelly has increased his holding to about £3.5m
That shows confidence.
John

2350220
09/7/2024
16:30
Nasdaq eventually. Sounded a little further off than Christmas
inaminute
09/7/2024
15:51
Are we all 'VERY EXCITED'.

Let's hope the AI program kicks off because Hvivo will be the largest benefactor.

chica1
09/7/2024
06:12
Zak catches up with #POLB https://www.share-talk.com/poolbeg-pharma-plc-chief-executive-officer-jeremy-skillington-phd-talking-to-zak-mir/
burtond1
08/7/2024
06:59
Great to see #POLB in the Times https://www.thetimes.com/world/ireland-world/article/biotech-boss-takes-clinical-approach-to-acquiring-unloved-assets-29sh8wjvh
burtond1
04/7/2024
08:15
Nice profit there;)
baldrick1
04/7/2024
07:23
Witty to sell at this level.
baldrick1
03/7/2024
09:02
🥱 🥱
chica1
03/7/2024
07:01
If that counts as witty where you are from I guess we cannot expect more
inaminute
02/7/2024
18:01
U just did man so I guess it applies to u..
Don't you know they're 2 words!

Why can't the English teach their children how to speak??😔 8532;😔

chica1
02/7/2024
17:10
Anybody who uses alot has a big moron sign on their forehead
inaminute
02/7/2024
14:50
Absolutely right Peter,Pogue like most of the morons on here don't like to see the other side of the coin.

The U-turn on POLB001 sent it back to Pre-Clinical.
Long long road and alotta more pigs at the trough to feed with the hires late last year.
Only bet what you can afford to lose!!!

chica1
02/7/2024
12:04
OK no worries you seem a normal poster. Time will indeed tell.
pogue
02/7/2024
11:48
No problem Pogue we'll just agree to disagree on this one. Will know before too long who called it right. I hold plenty so I expect some upside either way it plays out.
peterrr3
02/7/2024
11:38
peterr3
I will spell it out as I feel you were listening to the wrong bits there.
The lead asset of POLB is POLB001 and will be the first monetized. 2 pharmas are interested in it as their new very powerful cancer drugs have the side effect of cytokine storms. Cytokline storms mean that patients tie up hospital beds in cancer units thus reducing the amount of drugs that can be administered so huge incentive to find a drug that prevents them happening, like POLB001. Hugh incentive there for a phamra to partner with POLB if POLB001 works. Now as a stand alone drug POLB001 does the job all they have to do is prove it works whilst other drugs are in a patients system. The 2 pharmas have already given POLB the drugs, worth £millions, to run the trial and will pay for the trial as the market for their drug is 10s of $billions. We await the trial date how long do you think the pharmas are going to wait with a prize of that size?
Now the other part you need to research is what normally happens in these situations ie a drug going to trial with another and what the trial contract normally says baring in mind that if it proves successful the value of POLB001 goes through the roof. Clue the contract has a section on that and I strongly suggest that is the reason for the delay as its a very important section..
Sorry if very direct but you have missed the point completely of what is happening and this board has so many halfwit derampers who avoid basic facts that I treat posters I dont know with suspicion.

pogue
02/7/2024
09:51
Pogue we must be listening to different presentations because you don't really need to read between the lines to understand the carefully chosen words and they are very carefully chosen. The example he provides of using an income producing asset to fund the pipeline was a clear short to medium time plan. The mention they almost bought into something not long ago but it didn't stack up. The repeated mention of more orphan drugs, which POLB ain't is the main focus. There's simply not enough money to do much with the current pipeline.
peterrr3
01/7/2024
20:54
Pogue you use alot of words to say absolutely nothing.You honestly believe everything management of a company tells you.
Tell that to the sunken shareholders of Deepverge/Modern Water who were conned by their Ex CEO Gerald Brandon.
That being said I think Jeremy is a decent bloke and it's the only reason I'll retain half my distribution.

chica1
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock